We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$228M
AUM Growth
+$28.2M
Cap. Flow
+$16.3M
Cap. Flow %
7.18%
Top 10 Hldgs %
22.49%
Holding
2,261
New
155
Increased
919
Reduced
268
Closed
73

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$3.24M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.22M
3
VGT icon
Vanguard Information Technology ETF
VGT
+$1.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.05M
5
MLPI
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
+$1.04M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$12.5M
2
HD icon
Home Depot
HD
+$5.18M
3
IWB icon
iShares Russell 1000 ETF
IWB
+$555K
4
ESRX
Express Scripts Holding Company
ESRX
+$401K
5
IWM icon
iShares Russell 2000 ETF
IWM
+$401K

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Healthcare 8.96%
3 Consumer Staples 8.9%
4 Technology 8.86%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUB icon
1301
Atlantic Union Bankshares
AUB
$5.99B
$2K ﹤0.01%
+69
New +$2.47K
AVY icon
1302
Avery Dennison
AVY
$12.3B
$2K ﹤0.01%
31
– –
AYI icon
1303
Acuity Brands
AYI
$9.88B
$2K ﹤0.01%
13
– –
AZTA icon
1304
Azenta
AZTA
$1.26B
$2K ﹤0.01%
119
– –
BCO icon
1305
Brink's
BCO
$5.02B
$2K ﹤0.01%
46
– –
BIO icon
1306
Bio-Rad Laboratories Class A
BIO
$8.42B
$2K ﹤0.01%
17
+4
+31% +$770
BRO icon
1307
Brown & Brown
BRO
$22.9B
$2K ﹤0.01%
126
– –
CAR icon
1308
Avis
CAR
$5.63B
$2K ﹤0.01%
97
– –
CBRL icon
1309
Cracker Barrel
CBRL
$1.2B
$2K ﹤0.01%
+13
New +$2.08K
CHRD icon
1310
Chord Energy
CHRD
$7.79B
$2K ﹤0.01%
174
– –
CLDT
1311
Chatham Lodging
CLDT
$630M
$2K ﹤0.01%
+147
New +$2.95K
CNK icon
1312
Cinemark Holdings
CNK
$3.82B
$2K ﹤0.01%
90
+3
+3% +$126
COHR icon
1313
Coherent
COHR
$55.2B
$2K ﹤0.01%
56
– –
COLB icon
1314
Columbia Banking Systems
COLB
$8.81B
$2K ﹤0.01%
85
– –
CORT icon
1315
Corcept Therapeutics
CORT
$10.2B
$2K ﹤0.01%
+192
New +$1.69K
CTRE icon
1316
CareTrust REIT
CTRE
$10.2B
$2K ﹤0.01%
131
– –
CUZ icon
1317
Cousins Properties
CUZ
$5.29B
$2K ﹤0.01%
78
– –
CWT icon
1318
California Water Service
CWT
$3.04B
$2K ﹤0.01%
93
– –
CXT icon
1319
Crane NXT
CXT
$3.04B
$2K ﹤0.01%
78
-1,290
-94% -$33K
CYH icon
1320
Community Health Systems
CYH
$385M
$2K ﹤0.01%
260
– –
DAR icon
1321
Darling Ingredients
DAR
$9.93B
$2K ﹤0.01%
158
– –
DDS icon
1322
Dillards
DDS
$8.87B
$2K ﹤0.01%
56
+30
+115% +$1.64K
DLB icon
1323
Dolby
DLB
$4.72B
$2K ﹤0.01%
56
– –
DOC icon
1324
Healthpeak Properties
DOC
$15.4B
$2K ﹤0.01%
99
-314
-76% -$9.64K
EXPD icon
1325
Expeditors International
EXPD
$22.9B
$2K ﹤0.01%
94
+10
+12% +$548
51 52
53
54 55

Similar funds

BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $3.34B AUM 11.13% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM

Quadrant Capital Group's Q1 2017 Portfolio in Review

As of Q1 2017, Quadrant Capital Group held 2,261 positions worth $228M, up 14% from $199M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Quadrant Capital Group deployed $16.3M of net new capital in Q1 2017, opening 155 new positions and adding to 919 existing holdings. Its largest new stake was Meridian Bioscience Inc: 158,483 shares worth $2.19M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Procter & Gamble, an estimated $12.5M trimmed.

  • Quadrant Capital Group's largest Q1 2017 buy was Meridian Bioscience Inc: 158,483 shares worth $2.19M.
  • Quadrant Capital Group added most to Vanguard Total Stock Market ETF in Q1 2017, an estimated $3.24M increase.
  • Quadrant Capital Group's biggest Q1 2017 reduction was Procter & Gamble, cutting an estimated $12.5M.
  • Quadrant Capital Group fully exited Harman International Industries in Q1 2017, selling an estimated $104K.
  • Quadrant Capital Group's ten largest holdings make up 22% of its $228M portfolio in Q1 2017.
  • Quadrant Capital Group opened 155 new positions and closed 73 in Q1 2017.
  • Quadrant Capital Group's portfolio value rose 14% quarter-over-quarter to $228M.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.